SecBot SecBot

KALA

KALA BIO, Inc.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001479419 Biotech & Drug Discovery
$0.1390 −0.02 (−13.66%)
Nov 13 4:00 PM ET · prev $0.1610
Market cap
$3.1M
Nano cap
1 year
−99.6%
from $34.95 · Nov 17
30 days
−28.0%
from $0.1930
52-week range
$0.1390–66.50
at the low
Avg volume 20D
230.8K
Nov 13 spike 935.0K
Short interest
382.8K
≈2.0% of shares · −29.0%
Days to cover
1.8
at average volume
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
8
analyzed by SecBot
SecBot read BEARISH 6 reports · 90 days
Balance 3 bearish · 0 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 4/6

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q3 2026: 1 added (0 new), 2 trimmed or exited.

  • Short sellersCOVERING

    Short interest −29.0% to 382.8K shares. 1.8 days to cover, ≈2.0% of shares.

  • TrendDOWNTREND

    58% below its 50-day average. New closing low $0.1390 on Nov 13.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
BARCLAYS PLCNEAR_EXIT1Not reported
UBS Group AGNEAR_EXIT1,345$577.00
MORGAN STANLEYDOUBLED124$54.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Sep 2025
Recent actions
DateFirmActionRating
Sep 29, 2025HC Wainwright & Co.
DOWNGRADE
DOWNGRADENeutral
Sep 17, 2025HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Sep 11, 2025Oppenheimer
MAINTAIN
MAINTAINOutperform
Sep 8, 2025Mizuho
INITIATE
INITIATEOutperform
May 23, 2025HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Apr 4, 2025HC Wainwright & Co.
REITERATE
REITERATEBuy

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current QNoneNoneNo data$0.00
Next QNoneNoneNo data$0.00
Current FYNoneNoneNo data$0.00
Next FYNoneNoneNo data$0.00
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
2 drugs tracked · Drug pipeline →
Recent

SecBot reports

8 filings · 2 press releases · 0 bullish · 5 bearish · 3 neutral
All KALA filing & press-release reports (10)